Company: BDRX
Filing Date: 2025-05-12
Form Type: 424B3
Source: 0001214659-25-007342
Chunk: 11

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-12
Form: 424B3
Chunk 11
---
 in our financial statements and the related notes, you should consider carefully the risks described below. The risks and uncertainties described below are not the only risks and uncertainties we may face. Additional risks and uncertainties not presently known to us, or that we currently consider immaterial could also negatively affect our business, financial condition, results of operations, prospects, profits and stock prices. If any of the risks described below actually occur, our business, financial condition, results of operations, prospects, profits and stock prices could be materially adversely affected.

The sale of a substantial amount of our Ordinary Shares (represented by Depositary Shares), including resale of the Ordinary Shares (represented by Depositary Shares) issuable upon the exercise of the warrants held by the selling shareholders in the public market could adversely affect the prevailing market price of our Ordinary Shares and/or Depositary Shares.

We are registering for resale
341,352,000,000 Ordinary Shares represented by 34,135,200 Depositary Shares issuable upon the exercise of warrants held by the selling
shareholders. Sales of substantial amounts of our Ordinary Shares and/or Depositary Shares in the public market, or the perception that
such sales may occur, could adversely affect the market price of our Ordinary Shares and/or Depositary Shares. We cannot predict if and
when selling shareholders may sell such shares in the public markets. Furthermore, in the future, we may issue additional Ordinary Shares
(including Ordinary Shares represented by Depositary Shares). Any such issuance could result in substantial dilution to our existing shareholders
and could cause our share price to decline.

| 10 |

<div align='center'>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</div>

This prospectus contains certain
forward-looking information about the Company that is intended to be covered by the safe harbor for “forward-looking statements”
provided by the Private Securities Litigation Reform Act of 1995. These statements may be made directly in this prospectus or may be incorporated
into this prospectus by reference to other documents. Our representatives may also make forward-looking statements. Forward-looking statements
are statements that are not historical facts. Words such as “expect,” “believe,” “will,” “may,”
“anticipate,” “plan,” “estimate,” “intend,” “should,” “can,” “likely,”
“could” and similar expressions are intended to identify forward-looking statements. Forward-looking statements appear in
a number of places throughout this prospectus and include statements regarding our intentions, beliefs, assumptions, projections